Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

CAT

  • You have access
    Catalase Expression Is an Independent Prognostic Marker in Lung Adenocarcinoma
    PO-MING CHEN, YU-HAN HUANG, HSIN-HUNG CHEN and PEI-YI CHU
    Anticancer Research January 2024, 44 (1) 287-300; DOI: https://doi.org/10.21873/anticanres.16811
  • Open Access
    Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
    EVANGELOS DIMAKAKOS, GEORGIA GOMATOU, MARIELLA CATALANO, DAN-MIRCEA OLINIC, ALEX C. SPYROPOULOS, ANNA FALANGA, ANTHONY MARAVEYAS, AARON LIEW, SAM SCHULMAN, JILL BELCH, GRIGORIOS GEROTZIAFAS, PETER MARSCHANG, BENILDE COSMI, JONAS SPAAK, KONSTANTINOS SYRIGOS and CANCER-COVID-19 THROMBOSIS COLLABORATIVE GROUP, endorsed by VAS-European Independent Foundation in Angiology/Vascular Medicine, UEMS Vascular Medicine/Angiology and European Society of Vascular Medicine, and supported by the Balkan Working Group for Prevention and Treatment of Venous Thromboembolism and Hellenic Association of Lung Cancer
    Anticancer Research July 2022, 42 (7) 3261-3274; DOI: https://doi.org/10.21873/anticanres.15815
  • You have access
    Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental
    PAVLOS PAPAKOTOULAS, NIKOLAOS TSOUKALAS, ATHINA CHRISTOPOULOU, ALEXANDROS ARDAVANIS, GEORGIOS KOUMAKIS, CHRISTOS PAPANDREOU, GEORGIOS PAPATSIMPAS, PAVLOS PAPAKOSTAS, GEORGIOS SAMELIS, CHARALAMBOS ANDREADIS, GERASIMOS ARAVANTINOS, NIKOLAOS ZIRAS, CHARALAMBOS KALOFONOS, EPAMEINONDAS SAMANTAS, MARIA SOUGGLERI, PARIS MAKRANTONAKIS, GEORGIOS PENTHEROUDAKIS, ATHANASIOS ATHANASIADIS, HELEN STERGIOU, SOFIA TRIPODAKI, ALEXANDROS BOKAS, ANASTASIOS GRIVAS, ELENI TIMOTHEADOU, EVANGELOS BOURNAKIS, IOANNIS VARTHALITIS and IOANNIS BOUKOVINAS
    Anticancer Research January 2020, 40 (1) 305-313; DOI: https://doi.org/10.21873/anticanres.13954
  • You have access
    Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer
    EDYTA WIECZOREK, ZBIGNIEW JABLONOWSKI, BARTLOMIEJ TOMASIK, JOLANTA GROMADZINSKA, EWA JABLONSKA, TOMASZ KONECKI, WOJCIECH FENDLER, MAREK SOSNOWSKI, WOJCIECH WASOWICZ and EDYTA RESZKA
    Anticancer Research February 2017, 37 (2) 841-848;
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire